Prevention of Influenza by the Intranasal Administration of Cold-Recombinant, Live-Attenuated Influenza Virus Vaccine: Importance of Interferon-? Production and Local IgA Response 1995
Box 9
Cytokines and the Acute Phase Response to Influenza Virus in Mice 1995
Box 9
Gene Analysis of Reassortant Influenza Virus by RT-PCR Followed by Restriction Enzyme Digestion 1996
Box 9
Evaluation of Candidate Strains of Live-Attenuated Respiratory Syncytial Virus (RSV) for Human Vaccine 1996
Box 9
Phenotypic Characteristics of A/AA/6/60 Viruses and Reassortants 1996
Box 9
Sequence Comparisons of A/AA/6/60 Influenza Viruses: Mutations Which May Contribute to Attenuation 1996
Box 9
Chemokine Profile in MRC5 Cells Infected with Respiratory Syncytial Virus (RSV) 1997
(abstract and presentation slides only)
Box 9
The Cell Receptor Level is Reduced During Persistent Infection with Influenza Virus C 1997
Box 9
Studies in the Development of Live Attenuated Cold-Adapted Influenza Virus Vaccine for Humans 1997
Box 9
The Role of Respiratory Syncytial Virus (RSV) in Exacerbation of Airway Reactivity circa 1997
Principle of Cold-Adaptation in the Derivation of Live Attenuated Respiratory Virus Vaccines, Chapter in Biotechnological Applications of Cold-Adapted Organisms, 1998.
Box 9
IL-12 cDNA Skin Transfection Potentiates Human Papillomavirus E6 DNA Vaccine-Induced Antitumor Immune Response 1998
Box 9
Immunological Properties of Plaque Purified Strains of Live Attenuated Respiratory Syncytial Virus (RSV) for Human Vaccine 1999
Box 9
Live Influenza Virus Vaccine, Chapter in 3rd edition of Vaccines 1999